EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Declining Antibody Affinity Over Time After Human Vaccination With a Plasmodium falciparum Merozoite Vaccine Candidate

Kristina E M Persson, Jessica L Horton, Liriye Kurtovic, James S McCarthy, Robin F Anders, James G Beeson iD

The Journal of Infectious Diseases · 2024

DOI: 10.1093/infdis/jiae259 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Kristina E M Persson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Lund University, Lund, Sweden. Hauptthemen laut MEDLINE: Malaria Vaccines, Plasmodium falciparum, Malaria, Falciparum, Antibodies, Protozoan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Health and Medical Research Council, Avtal om Läkarutbildning och Forskning, Region Skåne.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Maintaining high-affinity antibodies after vaccination may be important for long-lasting immunity to malaria, but data on induction and kinetics of affinity is lacking. In a phase 1 malaria vaccine trial, antibody affinity increased following a second vaccination but declined substantially over 12 months, suggesting poor maintenance of high-affinity antibodies. Clinical Trials Registration Australian New Zealand Clinical Trials Registry ACTRN12607000552482.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Malaria VaccinesPlasmodium falciparumMalaria, FalciparumAntibodies, ProtozoanAntibody AffinityHumansMerozoitesAdultVaccinationMaleFemaleYoung AdultAustraliaAdolescent

Stichwörter der Autor:innen

affinity maintenanceantibodyantibody affinitymalariamalaria vaccine

Substanzen

Malaria VaccinesAntibodies, Protozoan

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Lund University, Lund, Sweden.
  • Department of Clinical Chemistry and Pharmacology, Laboratory Medicine, Region Skåne, Lund, Sweden.
  • Burnet Institute, Melbourne, Victoria, Australia.
  • QIMR-Berghofer Medical Research Institute, QueenslandAustralia.
  • Victorian Infectious Diseases Services, Doherty Institute, University of Melbourne, Melbourne, Victoria, Australia.
  • Department of Biochemistry and Chemistry, La Trobe Institute for Molecular Sciences, La Trobe University, Bundoora, Victoria, Australia.

ORCID-Profile: James G Beeson

Förderung

  • National Health and Medical Research Council
  • Avtal om Läkarutbildning och Forskning
  • Region Skåne
  • Lund University

Zitieren

APA

Persson, K. E. M., Horton, J. L., Kurtovic, L., McCarthy, J. S., Anders, R. F., & Beeson, J. G. (2024). Declining Antibody Affinity Over Time After Human Vaccination With a Plasmodium falciparum Merozoite Vaccine Candidate. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae259

Vancouver

Persson KEM, Horton JL, Kurtovic L, McCarthy JS, Anders RF, Beeson JG. Declining Antibody Affinity Over Time After Human Vaccination With a Plasmodium falciparum Merozoite Vaccine Candidate. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiae259

BibTeX
@article{Persson2024,
  author = {Persson, Kristina E M and Horton, Jessica L and Kurtovic, Liriye and McCarthy, James S and Anders, Robin F and Beeson, James G},
  title = {Declining Antibody Affinity Over Time After Human Vaccination With a Plasmodium falciparum Merozoite Vaccine Candidate},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  doi = {10.1093/infdis/jiae259}
}
Kostenlos starten →